Evidence map›Paper›PMID 23090478›Full record

ArticleMolecular biology reports2012

ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia.

Luke R G Pike, Kanchan Phadwal, Anna Katharina Simon, Adrian L Harris

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Inhibiting neddylation: A new strategy for tumor therapy.Journal of pharmaceutical analysis · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Tocotrienols Modulate a Life or Death Decision in Cancers.International journal of molecular sciences · 2019
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Luke R G PikeGrowth Factor Group, Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, Oxford, OX3 9DS, UK. lrgpike@gmail.com
Kanchan Phadwal
Anna Katharina Simon
Adrian L Harris
John Radcliffe Hospital · GB

Funding

Biotechnology and Biological Sciences Research Council BB/G021422/1Cancer Research UK 11359Department of Health NF-SI-0611-10163
6 · The paper itself

Abstract

Intratumoral hypoxia is associated with poor prognosis, regardless of the mode of therapy. Cancer cells survive this condition through activating several adaptive signaling pathways, including the integrated stress response (ISR) and autophagy. Activating transcription factor 4 (ATF4) is the major transcriptional mediator of the ISR, which we have shown to be involved in autophagy regulation to protect cells from severe hypoxia. Here we demonstrate that ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia. We find that the BH3-only proteins HRK, PUMA, and NOXA are transcriptionally induced in severe hypoxia and that their expression is abrogated by RNA interference against ATF4. In particular, we show that the BH3-only protein harakiri (HRK) is transactivated by ATF4 in severe hypoxia through direct binding of ATF4 to the promoter region. Furthermore, we demonstrate through siRNA knockdown that HRK induces autophagy and promotes cancer cell survival in severe hypoxia.

Indexed as

Activating Transcription Factor 4Apoptosis Regulatory ProteinsAutophagyBreast NeoplasmsCell HypoxiaCell Line, TumorCell SurvivalFemaleGene Expression Regulation, NeoplasticGene Knockdown TechniquesGenes, NeoplasmHumansOligonucleotide Array Sequence AnalysisPromoter Regions, GeneticProtein BindingProto-Oncogene ProteinsActivating Transcription Factor 4Apoptosis Regulatory ProteinsATF4 protein, humanBBC3 protein, humanHRK protein, humanPMAIP1 protein, humanProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2

Identifiers

PMID23090478
OpenAlexW1995200161

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.